UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients

  • Reviewed and approved by:

    Publications Committee and the UHMS Board of Directors

  • There have been numerous recent inquiries regarding use of hyperbaric oxygen (HBO2) for patients with COVID-19. Questions have been raised pertinent to two possible mechanisms for HBO2 in this clinical context:

    •  support of oxygenation

    •  attenuation of pulmonary inflammation

    Based on a review of the current literature, discussion with hyperbaric researchers working on this topic, and senior UHMS members, the following conclusions and recommendations are provided.

  • Follow us